First FDA-Approved Study of Stem Cells to Treat Hearing Loss
From hearingreview.com
February 2
112
Children's Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
0
Likes



Comments (No comments)
Add your commentAsk questions, get answers.
Give the community your two cents.
Be the first by adding your comments.